•
Jan 25, 2020

Patterson Q3 2020 Earnings Report

Patterson Companies' third quarter performance improved with increased net sales and adjusted earnings.

Key Takeaways

Patterson Companies reported a 4.3% increase in net sales to $1.46 billion and a rise in adjusted earnings per diluted share to $0.47. The Dental segment showed strong growth, while the Animal Health segment also contributed to the overall positive results. The company has raised its fiscal year 2020 adjusted earnings guidance.

Net sales increased 4.3 percent year-over-year to $1.46 billion.

Adjusted operating margin increased 40 bps to 4.3 percent.

Dental segment internal sales increased 8.0 percent.

Delivered third-quarter GAAP earnings of $0.24 per diluted share and adjusted earnings of $0.47 per diluted share.

Total Revenue
$1.46B
Previous year: $1.4B
+4.2%
EPS
$0.47
Previous year: $0.38
+23.7%
Adjusted Operating Margin
4.3%
Previous year: 3.9%
+10.3%
Gross Profit
$312M
Previous year: $300M
+4.1%
Cash and Equivalents
$106M
Previous year: $117M
-9.6%
Free Cash Flow
-$164M
Previous year: -$136M
+21.1%
Total Assets
$3.51B
Previous year: $3.32B
+5.8%

Patterson

Patterson

Patterson Revenue by Segment

Forward Guidance

Patterson Companies raised its fiscal 2020 GAAP earnings guidance range to $0.49 to $0.54 per diluted share, and adjusted earnings guidance range to $1.50 to $1.55 per diluted share.

Revenue & Expenses

Visualization of income flow from segment revenue to net income